Comments

Ocular Therapeutix Stock Guidance

OCULNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$13.72

-0.67-4.66%

At close: Dec 17, 4:00 PM EST

$13.82

0.10.73%

After Hours: 7:25 PM EST

Overview News Earnings Options

Guidance

Analyst Ratings Insider Trades Short Interest Stock Report

Ocular Therapeutix Stock Guidance | NASDAQ:OCUL | Benzinga

Ocular Therapeutix issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/07/2023	OCUL	Ocular Therapeutix	FY	2023	—	—	—	$60.00M	$60.00M	$59.95M	Get Alert
08/07/2023	OCUL	Ocular Therapeutix	FY	2023	—	—	—	$55.00M	$60.00M	$59.05M	Get Alert
05/08/2023	OCUL	Ocular Therapeutix	FY	2023	—	—	—	$55.00M	$60.00M	$58.80M	Get Alert
03/06/2023	OCUL	Ocular Therapeutix	FY	2023	—	—	—	$55.00M	$60.00M	$69.98M	Get Alert

FAQ

Q

What is the most recent guidance for Ocular Therapeutix (OCUL)?

A

There have been no specific sales or earnings guidance reported for Ocular Therapeutix in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

WAVE Life Sciences Ltd

Supernus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc

Terns Pharmaceuticals Inc

ANI Pharmaceuticals Inc

Axsome Therapeutics Inc

Ligand Pharmaceuticals Inc

Jazz Pharmaceuticals PLC